G764-0635 Screening compound: 7'-fluoro-N-(2-fluorophenyl)-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]-1-carboxamide

G764-0635 Screening compound: 7'-fluoro-N-(2-fluorophenyl)-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]-1-carboxamide
G764-0635 Screening compound: 7'-fluoro-N-(2-fluorophenyl)-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G764-0635
7'-fluoro-N-(2-fluorophenyl)-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G764-0635

Molecular Formula

C22H20F2N4O (C22 H20 F2 N4 O)

Compound Name

7'-fluoro-N-(2-fluorophenyl)-5'H-spiro[piperidine-4,4'-pyrrolo[1,2-a]quinoxaline]-1-carboxamide

IUPAC name

7'-fluoro-N-(2-fluorophenyl)-5'H-spiro[piperidine-44'-pyrrolo[12-a]quinoxaline]-1-carboxamide

SMILES

O=C(Nc(cccc1)c1F)N(CC1)CCC11Nc(cc(cc2)F)c2-n2c1ccc2

InChI

InChI=1S/C22H20F2N4O/c23-15-7-8-19-18(14-15)26-22(20-6-3-11-28(19)20)9-12-27(13-10-22)21(29)25-17-5-2-1-4-16(17)24/h1-8,11,14,26H,9-10,12-13H2,(H,25,29)

InChI Key

WRFHTKKELYXXOT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15034165

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

394.42

Hydrogen Bond Acceptors Count

2.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.568

Distribution Coefficient, logD

4.568

Water Solubility, LogSw

-4.29

Polar Surface Area

38.517

Acid Dissociation Constant (pKa)

12.14

Base Dissociation Constant (pKb)

2.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.70

G764-0635 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with G764-0635 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G764-0635?
Check Price and Availability of G764-0635, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G764-0635 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G764-0635
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G764-0635
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G764-0635 available by request